Thiotepa

Thiotepa
Clinical data
Trade namesTepadina
Other namesN,N',N''(-triethylenethiophosphoramide, INN, Thiotepa, Tepadina, Tepylute
AHFS/Drugs.comMonograph
MedlinePlusa682821
License data
Pregnancy
category
  • AU: D
Routes of
administration
Intravenous, intracavitary, intravesical
ATC code
Legal status
Legal status
Pharmacokinetic data
MetabolismLiver (CYP2B6, CYP3A)
MetabolitesPhase 1: Tetraethylenepentamine (tepa)
Phase 2: Thiotepa-mercapturate
Elimination half-life1.5–4.1 hours
ExcretionKidney
6 hours for thiotepa
8 hours for TEPA
Identifiers
  • 1,1,1″-Phosphorothioyltriaziridine
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.000.124
Chemical and physical data
FormulaC6H12N3PS
Molar mass189.22 g/mol g·mol−1
3D model (JSmol)
Melting point51.5 °C (124.7 °F)
Solubility in water0.19 g/mL (water, 25 °C)
Freely soluble in alcohol, diethyl ether and chloroform mg/mL (20 °C)
  • S=P(N1CC1)(N2CC2)N3CC3
  • InChI=1S/C6H12N3PS/c11-10(7-1-2-7,8-3-4-8)9-5-6-9/h1-6H2 Y
  • Key:FOCVUCIESVLUNU-UHFFFAOYSA-N Y
 NY (what is this?)  (verify)

Thiotepa (N,N',N''(-triethylenethiophosphoramide, INN), sold under the brand name Tepadina among others, is an anti-cancer medication.

Thiotepa is an organophosphorus compound with the formula (C2H4N)3PS.